Market Summery
Market Research Future (MRFR) predicts the Global Contrast Media Market
size is projected to grow USD 4.2 billion at a CAGR 4.01% during
the forecast period of 2023 – 2030. The radiographic contrast agents market is
characterized by a dynamic interplay of technological advancements, evolving
regulatory landscapes, and growing demand for diagnostic imaging procedures.
Radiographic contrast agents, often referred to as contrast media, play a
pivotal role in enhancing the visibility of anatomical structures during
medical imaging procedures such as X-rays, computed tomography (CT), and
fluoroscopy. These agents are formulated to selectively absorb or scatter
X-rays, thereby accentuating the contrast between different tissues or organs
within the body. As medical imaging technologies continue to advance, there is
a corresponding increase in the diversity and efficacy of radiographic contrast
agents, driving market growth.
Key players
Prominent contrast media
companies are
AMAG Pharmaceuticals (US)
Bracco Diagnostic Inc. (Italy)
Lantheus Medical Imaging (U.S.)
Covidien (Ireland)
Mallinckrodt Pharmaceuticals (UK)
Targeson (US)
nanoPET Pharma GmbH (Germany)
NanoScan Imaging (US)
Medrad Inc. (US)
Guerbet Group (France)
Subhra Pharma Private Limited (India)
GE Healthcare (US)
CMC Contrast AB (Sweden)
Daiichi (Japan)
Bayer Healthcare Pharmaceuticals (Germany)
Despite the promising growth prospects, the radiographic contrast
agents market faces challenges stemming from
regulatory scrutiny, safety concerns, and competitive dynamics. Regulatory
agencies impose stringent requirements on the approval and use of contrast
media to ensure patient safety and efficacy. Additionally, the market is
witnessing intensifying competition with the entry of new players and the
emergence of innovative imaging modalities that may reduce reliance on
traditional contrast agents. However, these challenges are being met with
proactive strategies such as research and development investments in novel
formulations, strategic collaborations for market expansion, and a heightened
focus on addressing safety concerns through comprehensive risk management
practices. As a result, the radiographic contrast agents market is poised for
sustained growth, driven by technological innovation and the increasing
adoption of advanced diagnostic imaging techniques across a diverse range of
medical specialties.
Segmental Analysis
The segmental study of the Global Contrast Media
Market gives a compendious market overview that highlights key points of
the market that benefits our clients to identify growth opportunities of the
market. The contrast media market study is segmented into type, procedure,
application, and route of application.
Based on the type, the market is segmented into intravenous
contrast materials, iodine-based contrast media agents, and others.
Based on the application, the market is segmented into
nephrological disorders, oncology, cardiovascular disorders, and others.
Based on the route of administration, the market is segmented into
injectable, rectal, and oral.
Regional Insights
MRFR’s regional analysis of the Contrast Media Market gives a
holistic approach towards the demographic progress of the market in the
forecast years. Based on the region, the contrast media market is segmented
into Asia Pacific, North America, Europe, and the Rest-of-the-World (RoW).
North America is expected to dominate the market, holding a
significant market share owing to its strong technological infrastructure.
Increase in medical tourism, rise in the number of cancer patients and patients
suffering from chronic disorders, and market players likely to deliver
cost-competitive contrast media products are factors which are predicted to
fuel the regional market growth.
Robust economic improvement, existence of influential market
players, and technological advancements in the European region can augment the
regional market proliferation.
The contrast media market in the Asia Pacific region, led by the
rapidly proliferating healthcare sector and developing economy, has emerged as
a promising market, globally. Increasing markets in countries, such as Japan,
China, and India, are pushing up the growth in the regional market. Moreover,
the APAC Contrast Media Market is driven by the rising population and the
spreading awareness towards the functionalities of contrast media.
The rapidly growing healthcare industry and emerging economies
like India, Japan, and China in the Asia Pacific region, a huge population, and
increase in awareness towards benefits of contrast media are market dynamics
expected to drive the regional market growth.
Related Reports-
Relapsing-Remitting
Multiple Sclerosis
No comments:
Post a Comment